SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens
Research Grant
Administered By
Duke Human Vaccine Institute
Awarded By
National Institute of Allergy and Infectious Diseases
Start Date
September 2, 2022
End Date
June 30, 2027
Administered By
Duke Human Vaccine Institute
Awarded By
National Institute of Allergy and Infectious Diseases
Start Date
September 2, 2022
End Date
June 30, 2027